trending Market Intelligence /marketintelligence/en/news-insights/trending/u39xbrqq78acoun872z3ia2 content esgSubNav
In This List

Dova Pharmaceuticals plans common stock offering

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Dova Pharmaceuticals plans common stock offering

Dova Pharmaceuticals Inc. plans to sell 2.5 million of its common shares in an underwritten public offering.

The company also plans grant the underwriters an option to buy up to an additional 375,000 common shares.

J.P. Morgan Securities LLC, Jefferies LLC and Evercore Group LLC are serving as joint book-running managers for the offering.